Form 8-K - Current report:
SEC Accession No. 0001104659-24-092808
Filing Date
2024-08-26
Accepted
2024-08-26 14:39:25
Documents
13
Period of Report
2024-08-16
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2422196d1_8k.htm   iXBRL 8-K 22086
  Complete submission text file 0001104659-24-092808.txt   189504

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbdy-20240816.xsd EX-101.SCH 3033
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbdy-20240816_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbdy-20240816_pre.xml EX-101.PRE 22371
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2422196d1_8k_htm.xml XML 3328
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55066 | Film No.: 241240399
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)